On December 1, 2025, Apimeds Pharmaceuticals US, Inc. confirmed a 1-for-10 reverse stock split, effective March 26, 2026, pending a 20-day notice period. Each ten shares will convert into one share, with new trading commencing on the NYSE under the symbol 'APUS'.